IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 29 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $111,000 | – | 17,852 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 396,425 | $5,927,000 | 0.29% |
| Gradient Capital Advisors, LLC | 21,718 | $325,000 | 0.18% |
| Hillsdale Investment Management Inc. | 15,200 | $232,000 | 0.02% |
| Orion Portfolio Solutions, LLC | 15,821 | $237,000 | 0.01% |
| IFP Advisors, Inc | 1,960 | $30,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 300 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 7 | $0 | 0.00% |
| MORGAN STANLEY | 2,100 | $31,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,900 | $98,000 | 0.00% |